Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Krzysztof Łukawski & Stanisław J. Czuczwar. (2021) Understanding mechanisms of drug resistance in epilepsy and strategies for overcoming it. Expert Opinion on Drug Metabolism & Toxicology 17:9, pages 1075-1090.
Read now
Read now
Alessandra Morano, Martina Fanella, Mariarita Albini, Pierangelo Cifelli, Eleonora Palma, Anna Teresa Giallonardo & Carlo Di Bonaventura. (2020) Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects. Neuropsychiatric Disease and Treatment 16, pages 381-396.
Read now
Read now
Articles from other publishers (17)
Tafere Mulaw Belete. (2023) Recent Progress in the Development of New Antiepileptic Drugs with Novel Targets. Annals of Neurosciences 30:4, pages 262-276.
Crossref
Crossref
Shivani Saxena, Rajnish Kumar, Avijit Mazumder, Sunita Kumari, Divya Sharma, Sagar Joshi & Vikas Sharma. (2023) A Review on Synthetic Strategies for Useful Oxadiazole Derivatives in
Psychological Disorders. Mini-Reviews in Organic Chemistry 20:4, pages 324-332.
Crossref
Crossref
Mariana Babayeva & Zvi G. Loewy. (2023) Cannabis Pharmacogenomics: A Path to Personalized Medicine. Current Issues in Molecular Biology 45:4, pages 3479-3514.
Crossref
Crossref
Loredana Raciti, Caterina Formica, Gianfranco Raciti, Angelo Quartarone & Rocco Salvatore Calabrò. (2023) Gender and Neurosteroids: Implications for Brain Function, Neuroplasticity and Rehabilitation. International Journal of Molecular Sciences 24:5, pages 4758.
Crossref
Crossref
Pratik Chakraborty, Abhijit Dey, Abilash Valsala Gopalakrishnan, Kumari Swati, Shreesh Ojha, Anand Prakash, Dhruv Kumar, Rashmi K. Ambasta, Niraj Kumar Jha, Saurabh Kumar Jha & Saikat Dewanjee. (2023) Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders. Ageing Research Reviews 85, pages 101838.
Crossref
Crossref
Erica Zamberletti, Tiziana Rubino & Daniela Parolaro. (2021) Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder. Pharmacology & Therapeutics 226, pages 107878.
Crossref
Crossref
Rebekah de Nys, Raman Kumar & Jozef Gecz. (2021) Protocadherin 19 Clustering Epilepsy and Neurosteroids: Opportunities for Intervention. International Journal of Molecular Sciences 22:18, pages 9769.
Crossref
Crossref
Donald J. AbrahamJeffrey M. Witkin, Lalit K. Golani & Jodi L. Smith. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
30
.
Aaron M. Farrelly, Styliani Vlachou & Konstantinos Grintzalis. (2021) Efficacy of Phytocannabinoids in Epilepsy Treatment: Novel Approaches and Recent Advances. International Journal of Environmental Research and Public Health 18:8, pages 3993.
Crossref
Crossref
Elena Chiurchiù, Susanna Sampaolesi, Pietro Allegrini, Daniele Ciceri, Roberto Ballini & Alessandro Palmieri. (2021) A Novel and Practical Continuous Flow Chemical Synthesis of Cannabidiol (CBD) and its CBDV and CBDB Analogues. European Journal of Organic Chemistry 2021:8, pages 1286-1289.
Crossref
Crossref
Peter B. Sampson. (2020)
Phytocannabinoid Pharmacology: Medicinal Properties of
Cannabis sativa
Constituents Aside from the “Big Two”
. Journal of Natural Products 84:1, pages 142-160.
Crossref
Crossref
Julio Riquelme, Mario Wellmann, Ramón Sotomayor-Zárate & Christian Bonansco. (2020) Gliotransmission: A Novel Target for the Development of Antiseizure Drugs. The Neuroscientist 26:4, pages 293-309.
Crossref
Crossref
Patrícia Alves, Cristina Amaral, Natércia Teixeira & Georgina Correia-da-Silva. (2020) Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol. Pharmacological Research 157, pages 104822.
Crossref
Crossref
Vicente Martínez, Amaia Iriondo De-Hond, Francesca Borrelli, Raffaele Capasso, María Dolores del Castillo & Raquel Abalo. (2020) Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?. International Journal of Molecular Sciences 21:9, pages 3067.
Crossref
Crossref
Stefan Wolking, Herbert Schulz, Anne T Nies, Mark McCormack, Elke Schaeffeler, Pauls Auce, Andreja Avbersek, Felicitas Becker, Karl M Klein, Martin Krenn, Rikke S Møller, Marina Nikanorova, Sarah Weckhuysen, EpiPGx Consortium, Gianpiero L Cavalleri, Norman Delanty, Chantal Depondt, Michael R Johnson, Bobby PC Koeleman, Wolfram S Kunz, Anthony G Marson, Josemir W Sander, Graeme J Sills, Pasquale Striano, Federico Zara, Fritz Zimprich, Yvonne G Weber, Roland Krause, Sanjay Sisodiya, Matthias Schwab, Thomas Sander & Holger Lerche. (2020) Pharmacoresponse in genetic generalized epilepsy: a genome-wide association study. Pharmacogenomics 21:5, pages 325-335.
Crossref
Crossref
Debopam Samanta. (2020) PCDH19-Related Epilepsy Syndrome: A Comprehensive Clinical Review. Pediatric Neurology 105, pages 3-9.
Crossref
Crossref
Xudong Gong, Changliang Sun, Melkamu Alemu Abame, Wenqiang Shi, Yuanchao Xie, Wanbin Xu, Fuqiang Zhu, Yan Zhang, Jingshan Shen & Haji A. Aisa. (2019) Synthesis of CBD and Its Derivatives Bearing Various C4′-Side Chains with a Late-Stage Diversification Method. The Journal of Organic Chemistry 85:4, pages 2704-2715.
Crossref
Crossref